Hudson Executive Capital LP - Q2 2020 holdings

$1.02 Billion is the total value of Hudson Executive Capital LP's 7 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 12.5% .

 Value Shares↓ Weighting
DB BuyDEUTSCHE BANK A Gnamen akt$1,233,466,000
+188.8%
129,722,952
+100.0%
60.18%
+11.3%
CATM BuyCARDTRONICS PLC$414,608,000
+143.9%
17,289,760
+112.7%
20.23%
-6.0%
USAT BuyUSA TECHNOLOGIES INC$154,512,000
+223.4%
22,041,530
+112.2%
7.54%
+24.6%
TVTY BuyTIVITY HEALTH INC$108,662,000
+97.3%
9,590,620
+9.5%
5.30%
-24.0%
VRAY BuyVIEWRAY INC$58,350,000
+79.2%
26,049,368
+100.0%
2.85%
-30.9%
STOR BuySTORE CAP CORP$42,420,000
+162.8%
1,781,600
+100.0%
2.07%
+1.3%
NTRA BuyNATERA INC$37,752,000
+233.9%
757,178
+100.0%
1.84%
+28.7%
SMG ExitSCOTTS MIRACLE GRO COcl a$0-292,237
-100.0%
-3.79%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
DEUTSCHE BANK AG21Q3 202388.0%
EAGLE PHARMACEUTICALS INC16Q4 201934.5%
NATERA INC15Q4 20224.6%
CARDTRONICS PLC14Q1 202143.3%
VIEWRAY INC14Q2 20238.2%
ATRICURE INC13Q3 201920.9%
CIT GROUP INC11Q2 201826.4%
TIVITY HEALTH INC11Q1 202212.3%
CORINDUS VASCULAR ROBOTICS I11Q3 20199.7%
CANTALOUPE INC10Q3 202311.8%

View Hudson Executive Capital LP's complete holdings history.

Latest significant ownerships (13-D/G)
Hudson Executive Capital LP Q2 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
ViewRay, Inc.July 21, 20236,752,0933.7%
Akoya Biosciences, Inc.February 07, 20231,892,2045.0%
Liberated Syndication Inc.March 23, 20222,400,0008.6%
eHealth, Inc.March 11, 2022750,5012.8%
Talkspace, Inc.November 17, 202117,980,60011.2%
USA TECHNOLOGIES INCFebruary 26, 202111,995,76516.9%
Cardtronics plcDecember 15, 20208,644,88019.4%
TIVITY HEALTH, INC.May 11, 20204,795,3109.9%
EAGLE PHARMACEUTICALS, INC.January 16, 2020361,8972.6%
Corindus Vascular Robotics, Inc.Sold outOctober 31, 201900.0%

View Hudson Executive Capital LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-15
1442024-02-21
42024-02-21
SC 13D/A2024-02-21
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
SC 13D/A2023-07-21
13F-HR2023-05-15
13F-HR2023-02-14

View Hudson Executive Capital LP's complete filings history.

Compare quarters

Export Hudson Executive Capital LP's holdings